OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RAF1 rearrangements are common in pancreatic acinar cell carcinomas
Owen W.J. Prall, Violeta Nastevski, Huiling Xu, et al.
Modern Pathology (2020) Vol. 33, Iss. 9, pp. 1811-1821
Open Access | Times Cited: 34
Owen W.J. Prall, Violeta Nastevski, Huiling Xu, et al.
Modern Pathology (2020) Vol. 33, Iss. 9, pp. 1811-1821
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies
Melody Riaud, Jennifer Maxwell, Isabel Soria‐Bretones, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 2, pp. 105-122
Closed Access | Times Cited: 22
Melody Riaud, Jennifer Maxwell, Isabel Soria‐Bretones, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 2, pp. 105-122
Closed Access | Times Cited: 22
Fusion genes in pancreatic tumors
Αναστάσιος Γκουντάκος, Aatur D. Singhi, C. Benedikt Westphalen, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 430-443
Open Access | Times Cited: 10
Αναστάσιος Γκουντάκος, Aatur D. Singhi, C. Benedikt Westphalen, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 430-443
Open Access | Times Cited: 10
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective Study
Cody Eslinger, Bobak Seddighzadeh, Claire Yee, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access | Times Cited: 1
Cody Eslinger, Bobak Seddighzadeh, Claire Yee, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access | Times Cited: 1
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Penglei Wang, Kyle Vaughn Laster, Xuechao Jia, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Penglei Wang, Kyle Vaughn Laster, Xuechao Jia, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Pediatric pancreatic acinar cell carcinoma with a non-canonical BRAF-KMT2C fusion and a classic SND1-BRAF fusion: a case report and literature review
Yaqin Wang, Zhang Jiasi, Dimin Nie, et al.
BMC Pediatrics (2025) Vol. 25, Iss. 1
Open Access
Yaqin Wang, Zhang Jiasi, Dimin Nie, et al.
BMC Pediatrics (2025) Vol. 25, Iss. 1
Open Access
A Novel ACVR2A::RAF1 Fusion in Spindle Cell Sarcoma
Anfeng Jiang, Huan Li, Dongbing Li, et al.
Genes Chromosomes and Cancer (2025) Vol. 64, Iss. 2
Closed Access
Anfeng Jiang, Huan Li, Dongbing Li, et al.
Genes Chromosomes and Cancer (2025) Vol. 64, Iss. 2
Closed Access
Peipei Zhu, Xuewei Zeng, Linjie Yang, et al.
Histopathology (2025)
Closed Access
Compositional Analysis of Eight Edible Seaweeds and Potential Anti-tumor Mechanisms of the Differential Components Based on UPLC-QE-MS/MS, Network Pharmacology and Molecular docking
Do Thi Xuan, Baoguo Chen, Zheng Zhou, et al.
Food Bioscience (2025), pp. 106506-106506
Closed Access
Do Thi Xuan, Baoguo Chen, Zheng Zhou, et al.
Food Bioscience (2025), pp. 106506-106506
Closed Access
A Novel GLCCI1::BRAF Fusion With Independent MYC and MYCN Amplifications in Pediatric Pancreatic Acinar Cell Carcinoma
Lauren J. Miller, Amer Heider, Lina Shao
Pediatric and Developmental Pathology (2025)
Closed Access
Lauren J. Miller, Amer Heider, Lina Shao
Pediatric and Developmental Pathology (2025)
Closed Access
Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma
Meredith S. Pelster, Ian M. Silverman, Joseph D. Schonhoft, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Meredith S. Pelster, Ian M. Silverman, Joseph D. Schonhoft, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Nebojša Skorupan, Shadin Ghabra, J. Alberto Maldonado, et al.
Journal of Cancer Metastasis and Treatment (2023) Vol. 9
Open Access | Times Cited: 6
Nebojša Skorupan, Shadin Ghabra, J. Alberto Maldonado, et al.
Journal of Cancer Metastasis and Treatment (2023) Vol. 9
Open Access | Times Cited: 6
Why did they change that? Practical implications of the evolving classification of neuroendocrine tumours of the gastrointestinal tract
Anthony J. Gill
Histopathology (2020) Vol. 78, Iss. 1, pp. 162-170
Closed Access | Times Cited: 14
Anthony J. Gill
Histopathology (2020) Vol. 78, Iss. 1, pp. 162-170
Closed Access | Times Cited: 14
Charlotte Paoli, Fanny Burel‐Vandenbos, Aurore Coulomb‐L'Herminé, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 12, pp. 734-739
Open Access | Times Cited: 9
The Molecular and Pathophysiological Functions of Members of the LNX/PDZRN E3 Ubiquitin Ligase Family
Jeongkwan Hong, Minho Won, Hyunju Ro
Molecules (2020) Vol. 25, Iss. 24, pp. 5938-5938
Open Access | Times Cited: 12
Jeongkwan Hong, Minho Won, Hyunju Ro
Molecules (2020) Vol. 25, Iss. 24, pp. 5938-5938
Open Access | Times Cited: 12
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?
Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Angelo Borsarelli Carvalho Brito, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Angelo Borsarelli Carvalho Brito, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Pancreatoblastoma with a novel fusion gene ofIQSEC1‐RAF1
Hironori Goto, Yuhki Koga, Kenichi Kohashi, et al.
Pediatric Blood & Cancer (2022) Vol. 70, Iss. 4
Closed Access | Times Cited: 6
Hironori Goto, Yuhki Koga, Kenichi Kohashi, et al.
Pediatric Blood & Cancer (2022) Vol. 70, Iss. 4
Closed Access | Times Cited: 6
Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic Pancreatic Cancer
Deepak Bhamidipati, Sireesha Yedururi, Jason T. Huse, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 3
Deepak Bhamidipati, Sireesha Yedururi, Jason T. Huse, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 3
Gene fusions in gastrointestinal tract cancers
Hamed Rahi, Maria C. Olave, Karen Fritchie, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 5, pp. 285-297
Closed Access | Times Cited: 5
Hamed Rahi, Maria C. Olave, Karen Fritchie, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 5, pp. 285-297
Closed Access | Times Cited: 5
BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation
Toshi Ghosh, Patricia T. Greipp, Darlene L. Knutson, et al.
Archives of Pathology & Laboratory Medicine (2021) Vol. 146, Iss. 7, pp. 840-845
Open Access | Times Cited: 7
Toshi Ghosh, Patricia T. Greipp, Darlene L. Knutson, et al.
Archives of Pathology & Laboratory Medicine (2021) Vol. 146, Iss. 7, pp. 840-845
Open Access | Times Cited: 7
Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas
Jamal Benhamida, Monika Vyas, Atsushi Tanaka, et al.
Modern Pathology (2021) Vol. 35, Iss. 7, pp. 956-961
Open Access | Times Cited: 6
Jamal Benhamida, Monika Vyas, Atsushi Tanaka, et al.
Modern Pathology (2021) Vol. 35, Iss. 7, pp. 956-961
Open Access | Times Cited: 6
Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: Real-World Data
Sung Hee Lim, Sun-Young Jung, Jung Young Hong, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3264-3264
Open Access | Times Cited: 2
Sung Hee Lim, Sun-Young Jung, Jung Young Hong, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3264-3264
Open Access | Times Cited: 2
The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart
Joshua Abd Alla, Ursula Quitterer
Cells (2022) Vol. 11, Iss. 4, pp. 654-654
Open Access | Times Cited: 4
Joshua Abd Alla, Ursula Quitterer
Cells (2022) Vol. 11, Iss. 4, pp. 654-654
Open Access | Times Cited: 4
Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine
Rüveyda Ayasun, Turçin Saridogan, Ola Gaber, et al.
Clinical Colorectal Cancer (2022) Vol. 22, Iss. 1, pp. 2-11
Open Access | Times Cited: 4
Rüveyda Ayasun, Turçin Saridogan, Ola Gaber, et al.
Clinical Colorectal Cancer (2022) Vol. 22, Iss. 1, pp. 2-11
Open Access | Times Cited: 4
Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: A Real World Data
Sung Hee Lim, Sun-Young Jung, Jung Young Hong, et al.
(2023)
Open Access | Times Cited: 1
Sung Hee Lim, Sun-Young Jung, Jung Young Hong, et al.
(2023)
Open Access | Times Cited: 1
Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition
Irina Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Irina Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
